Diabetes Mellitus X

 

d.105

Goday A, Bellido D, Sayoux I. et al. Short-term safety, tolerability and efficacy of a low-carbohydrate-ketogenic diet interventional weight loss program versus hypocaloric diet in patients with type 2 diabetes mellitus. Nutrition & Diabetes 2016; 6, e230 DOI:10.1038/nutd.2016.36


·
d.106

C. Assaf-Balut, C. Familiar, N. García de la Torre, MA. Rubio, E. Bordiu, L. Del Valle, M. Lara, T. Ruiz, A. Ortolá, I. Crespo, A. Durán, MA. Herraiz, N. Izquierdo, N. Pérez, MJ. Torrejón, I. Runkle, C. Montáñez, AL. Calle-Pascual. Gestational diabetes mellitus treatment reduces obesity-induced adverse pregnancy and neonatal outcomes: the St. Carlos gestational study. BMJ Open Diabetes Research & Care. 2016; 4:e000314. doi:10.1136/bmjdrc-2016-000314.


·
d.107

Aroda V, Rosenstock J, Wysham C, Unger J, Bellido D. et al. Efficacy and Safety of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatida in Patients With Type 2 Diabetes Inadequately Controlled on Basal Insulin: The LixiLan-L Randomized Trial. Diabetes Care. 2016; 39; 11: 1972-1980 DOI: 10.2337/dc16-1495


·
d.108

Conget I, Mauricio D, Ortega R, Deteoumay B on behalf of the CHADIG Study investigators. (Bellido D). Characteristics of patients with type 2 diabetes mellitus newly treated with GLP-1 receptor agonists (CHADIG Study): a cross-sectional multicenter study in Spain. BMJ Open 2016; 6:e010197. doi:10.1136/bmjopen-2015- 010197


·
d.109

Prasad V, Sainz-Esteban A, Arsenic R, Plöckinger U, Denecke T, Pape UF, Pascher A, Kühnen P, Pavel M, Blankenstein O. Role of (68)Ga somatostatin receptor PET/CT in the detection of endogenous hyperinsulinaemic focus: an explorative study. Eur J Nucl Med Mol Imaging. 2016 Aug;43(9):1593-600.


·